Covered recipient · General Payments record
VERONICA CIESZYNSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$1,104.37
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.90 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $104.90 | 5 |
| Amgen Inc. | $56.43 | 3 |
| Lilly USA, LLC | $40.56 | 2 |
| Novo Nordisk AS | $37.95 | 2 |
| GlaxoSmithKline, LLC. | $29.47 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.15 | 1 |
| Phathom Pharmaceuticals, Inc. | $23.69 | 1 |
| Abbott Laboratories | $22.47 | 1 |
| PFIZER INC. | $15.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.47 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042456 | CMS |
| ABBVIE INC. | $16.91 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106920165 | CMS |
| ABBVIE INC. | $19.36 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106920167 | CMS |
| ABBVIE INC. | $32.97 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106920169 | CMS |
| ABBVIE INC. | $16.42 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106920171 | CMS |
| ABBVIE INC. | $19.24 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106920173 | CMS |
| Amgen Inc. | $15.79 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117224674 | CMS |
| Amgen Inc. | $19.08 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117527683 | CMS |
| Amgen Inc. | $21.56 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117527685 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.15 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117991388 | CMS |
| GlaxoSmithKline, LLC. | $15.02 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116492671 | CMS |
| GlaxoSmithKline, LLC. | $14.45 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116101168 | CMS |
| Lilly USA, LLC | $24.08 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135987798 | CMS |
| Lilly USA, LLC | $16.48 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135983622 | CMS |
| Novo Nordisk Inc | $20.71 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100591600 | CMS |
| Novo Nordisk Inc | $17.24 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100642945 | CMS |
| PFIZER INC. | $15.28 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001067 | CMS |
| Phathom Pharmaceuticals, Inc. | $23.69 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151155899 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.